Usefulness of thrombophilia testing in venous thromboembolic disease: Findings from the RIETE registry

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 1, 2013, Pages 42-47

  Gabriel, Francisco ^a   Portoles O ^b   Labios M ^a   Rodriguez C ^c   Cisneros, E ^d   Vela, J ^e   Nunez M ^f  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL SAN JUAN DE DIOS DEL ALJARAFE   (Spain)

^d HOSPITAL SON LLÀTZER   (Spain)

^e Hospital de Alcañiz Alcañiz   (Spain)

^f Hospital Comarcal do Salnes   (Spain)

Author keywords

factor V Leiden; lower extremity deep vein thrombosis; prothrombin G20210A; upper extremity deep vein thrombosis; venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; ALANINE; BLOOD CLOTTING FACTOR 5 LEIDEN; GLYCINE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN;

ADULT; ARTICLE; BLEEDING; HUMAN; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGE FACTORS; AGED; FACTOR V; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROTHROMBIN; REGISTRIES; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84871553984     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611436193     Document Type: Article

References (31)

1. Coppola A, Tufano A, Cerbone AM, Di Mino G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost. 2009 ; 35 (7). 683-694
2. Engbers MJ, Van Hylckama A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010 ; 8 (10). 2105-2112
3. Rosendaal FR, Van Hylckama A, Doggen CJ. Venous thrombosis in the elderly. J Thromb Haemost. 2007 ; 5 (suppl 1). 310-317
4. Isma N, Svensson PJ, Gottsäter A, Lindblad B. Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res. 2010 ; 125 (6). e335 - e338
5. Blanco-Molina A, Rota L, Di Micco P, et al. RIETE investigators. Venous thromboembolism during pregnacy, postpartum or contraceptive use. Findings from the RIETE Registry. Thromb Haemost. 2010 ; 103 (2). 306-311
6. Gadelha T, Roldán V, Lecumberri R, et al. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry. Thromb Res. 2010 ; 126 (4). 283-286
7. Christiansen S, Cannegieter S, Koster T, Vandenbroucke J, Rosendaal F. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005 ; 293 (19). 2352-2361
8. Kistner RL, Eklöf B Handbook of Venous Disorders. Dalsing MC Eklöf B Moneta GL Wakefield TW, ed. London, UK: Hodder Arnold ; 2009: 37-45.
9. De Stefano V, Rossi E, Za T, Leone G. Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia. Semin Thromb Hemost. 2006 ; 32 (8). 767-780
10. Cohn D, Roshani S, Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost. 2007 ; 33 (6). 573-581
11. Bank I, Libourel E, Middeldorp S, et al. Prothrombin 20110A mutation. A mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med. 2004 ; 164 (17). 1932-1937
12. Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D, Lindhoff-Last E. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost. 2008 ; 100 (3). 440-446
13. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008 ; 112 (1). 19-27
14. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost. 2005 ; 3 (11). 2471-2478
15. Lechner D, Wiener C, Weltermann A, Eischer L, Eichinger S, Kyrle PA. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost. 2008 ; 6 (8). 1269-1274
16. Watson HG. Upper extremity deep vein thrombosis-not the same disease at a different site. J Thromb Haemost. 2008 ; 6 (8). 1267-1268
17. Kovac M, Mitic G, Mikovic Z, et al. Type and location of venous thromboembolism in carriers of factor V Leiden or prothrombin G 20210A mutation versus patients with no mutation. Clin Appl Thromb Hemost. 2010 ; 16 (1). 66-70
18. Hoffmann U, Spannagl M. Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue?. Thromb Haemost. 2008 ; 100 (3). 369-370
19. Spencer FA, Emery C, Lessard D, Goldberg RJ. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med. 2007 ; 120 (8). 678-684
20. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004 ; 110 (12). 1605-1611
21. Prandoni P, Polistena P, Bernardi E, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med. 1997 ; 157 (1). 57-62
22. Roldan V, Lecumberri R, Sánchez J, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009 ; 124 (2). 174-177
23. Simioni P, Tormene D, Spiezia L, et al. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost. 2006 ; 32 (7). 700-708
24. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008 ; 112 (1). 19-27
25. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of anticoagulation study group. Am J Med. 1998 ; 104 (4). 332-338
26. Kyrle P, Eichinger S. Deep vein thrombosis. Lancet. 2005 ; 365: 1163-1174
27. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American heart association. Circulation. 2011 ; 123 (16). 1788-1830
28. Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost. 2008 ; 6 (9). 1474-1477
29. Adam S, Key N, Greenberg C. D-dimer antigen: current concepts and future prospects. Blood. 2009 ; 113 (13). 2878-2887
30. Kearon C, Khan SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008 ; 133 (6 suppl). 454S - 545S
31. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010 ; 149 (2). 209-220